An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive digestive malignancy due to frequent late-stage diagnosis, rapid progression and resistance to therapy. With increasing PDAC incidence worldwide, there is an urgent need for new prognostic biomarkers and therapy targets. Recently, RNA me...
Main Authors: | Duo Yun, Zhirong Yang, Shuman Zhang, Hai Yang, Dongxue Liu, Robert Grützmann, Christian Pilarsky, Nathalie Britzen-Laurent |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.975684/full |
Similar Items
-
Integrated single-cell and spatial transcriptomic analysis reveals YBX1 drives immune regulation in GBM progression
by: Yanshan Ge, et al.
Published: (2024-04-01) -
m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine
by: Baoxiang Chen, et al.
Published: (2022-12-01) -
Developmental changes and sex differences in DNA methylation and demethylation in hypothalamic regions of the mouse brain
by: Carla D. Cisternas, et al.
Published: (2020-02-01) -
UHRF2 regulates local 5-methylcytosine and suppresses spontaneous seizures
by: Yidan Liu, et al.
Published: (2017-07-01) -
Levels of DNA cytosine methylation in the Drosophila genome
by: Saniya Deshmukh, et al.
Published: (2018-07-01)